About Domainex
Domainex is a company based in Cambridge (United Kingdom) founded in 2001.. Domainex has raised $4.97 million across 6 funding rounds from investors including YFM Equity Partners, Wellcome and Longbow Capital. The company has 93 employees as of January 31, 2022. Domainex offers products and services including Integrated Drug Discovery Services, Medicinal Chemistry, Structural Biology, and Assay Development. Domainex operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, NIH and Viva Biotech, among others.
- Headquarter Cambridge, United Kingdom
- Employees 93 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Domainex Limited
- Date of Incorporation 10 Dec, 2001
- Jurisdiction SAFFRON WALDEN, ENGLAND
-
Annual Revenue
$15.49 M (USD)19as on Dec 31, 2022
-
Net Profit
$1.85 M (USD)8as on Dec 31, 2022
-
EBITDA
-
Total Equity Funding
$4.97 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
YFM Equity Partners
& 4 more
-
Employee Count
93
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Domainex
Domainex offers a comprehensive portfolio of products and services, including Integrated Drug Discovery Services, Medicinal Chemistry, Structural Biology, and Assay Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Comprehensive platform for hit to lead optimization in pharmaceuticals
Design and synthesis of compounds for drug development
Techniques like X-ray crystallography for protein analysis
Creation of tests for evaluating drug candidates
Unlock access to complete
Unlock access to complete
Funding Insights of Domainex
Domainex has successfully raised a total of $4.97M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(01 Jun 2007)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2016 | Amount | Grant - Domainex | Valuation |
investors |
|
| Dec, 2012 | Amount | Series A - Domainex | Valuation |
investors |
|
| Nov, 2011 | Amount | Grant - Domainex | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Domainex
Domainex has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include YFM Equity Partners, Wellcome and Longbow Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Domainex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Domainex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Domainex Comparisons
Competitors of Domainex
Domainex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, NIH and Viva Biotech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Drug discovery and development services are provided to biopharma sector.
|
|
| domain | founded_year | HQ Location |
Cancer and CVMD drugs are developed using PDX models.
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided for therapeutic development.
|
|
| domain | founded_year | HQ Location |
Drug discovery services are provided to the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Drug discovery and development research services are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Domainex
Frequently Asked Questions about Domainex
When was Domainex founded?
Domainex was founded in 2001 and raised its 1st funding round 6 years after it was founded.
Where is Domainex located?
Domainex is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Is Domainex a funded company?
Domainex is a funded company, having raised a total of $4.97M across 6 funding rounds to date. The company's 1st funding round was a Grant of $398.38K, raised on Jun 01, 2007.
How many employees does Domainex have?
As of Jan 31, 2022, the latest employee count at Domainex is 93.
What is the annual revenue of Domainex?
Annual revenue of Domainex is $15.49M as on Dec 31, 2022.
What does Domainex do?
Domainex is a drug discovery CRO that develops small molecule compounds for epigenetic research and inflammatory diseases. Domainexs services include proprietary platforms based services such as Combinatorial Domain Hunting (for structural studies and assay development) and LeadBuilder (virtual and fragment-based approaches to hit identification), medicinal chemistry and computational chemistry services, protein expression capabilities and cell-based and biochemical assay development offering. The company had won the 1.4m Biomedical Catalyst Award for the success of its Lead Compound in Pre-clinical Model of COPD. Domainex merged with NCE Discovery in 2007 to form a drug discovery company focussed on nucleotide triphosphate (NTP)-dependent proteins. The companys clientele includes UCB, FORMA Therapeutics, St Georges University, The Institute of Cancer Research and Auspherix. Domainex claims that it has delivered on an average one candidate drug per year in the six years since 2010.
Who are the top competitors of Domainex?
Domainex's top competitors include Evotec, Crown Bioscience and NIH.
What products or services does Domainex offer?
Domainex offers Integrated Drug Discovery Services, Medicinal Chemistry, Structural Biology, and Assay Development.
Who are Domainex's investors?
Domainex has 5 investors. Key investors include YFM Equity Partners, Wellcome, Longbow Capital, Bury Fitzwilliam-Lay And Partners, and Takeda Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.